Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages 1414-1417

  Chen, Yan ^a   Stirling, Rob G ^a,b   Paul, Eldho ^b   Hore Lacy, Fiona ^a   Thompson, Bruce R ^a,b   Douglass, Jo A ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AUSTRALIA; BRONCHIECTASIS; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; DEMOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LETTER; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; X LINKED AGAMMAGLOBULINEMIA;

EID: 79957871077     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.03.041     Document Type: Article

References (10)

1. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006;117:S525-53.
2. Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol 2009;157(suppl 1):3-11.
3. Loebinger MR, Wells AU, Hansell DM, Cinyanganya N, Devaraj A, Meister M, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009;34:843-9.
4. Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures and fallacies. Thorax 1997;52:820-7. (Pubitemid 27412566)
5. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring cohort. Am J Respir Crit Care Med 2009;180:3-10.
6. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34. (Pubitemid 13101554)
7. Senn S, Stevens L, Chaturvedi N. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Stat Med 2000;19:861-77. (Pubitemid 30187381)
8. Haidopolou K, Calder A, Jones A, Jaffe A, Sonnappa S. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 2009;44:669-75.
9. Van Pelt W, Borsboom GJ, Rijcken B, Schouten JP, van Zomeren BC, Quanjer PH. Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med 1994; 149:1218-26. (Pubitemid 24147063)
10. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010;125: 1354-60.